March 02, 2015 10:50 PM ET

Biotechnology

Company Overview of Intercell USA, Inc.

Company Overview

Intercell USA, Inc., a biopharmaceutical company, provides a non-invasive technology solution for the delivery of vaccines to the skin. It offers transcutaneous immunization that allows delivery of all classes of vaccine components to the skin ranging from peptides to whole organisms. The company’s technology enables the delivery of potent biological molecules to the skin for vaccination and immuno-modulation that prevents or treats various diseases. Intercell USA, Inc. was formerly known as Iomai Corporation and changed its name to Intercell USA, Inc. in August 2008 and changed its name as a result of its acquisition by Intercell Ag. The company was founded in 1997 and is based in Gaithersb...

22 Firstfield Road

Suite 210

Gaithersburg, MD 20878

United States

Founded in 1997

110 Employees

Phone:

301-556-4500

Fax:

301-556-4501

Key Executives for Intercell USA, Inc.

Chief Executive Officer and Director
Age: 59
President and Director
Age: 51
Co-Founder, Chief Scientific Officer and Senior Vice President
Age: 60
Chief Financial Officer and Secretary
Age: 45
Vice President of Operations
Age: 46
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
MicroDiagnosis Inc. United States
DocPlanet.com Inc. United States
Bio-Tissue, Inc. United States
Abraxis BioScience, LLC United States
Metritrack, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intercell USA, Inc., please visit www.iomai.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.